Lorence H. Kim is CFO at Moderna, Inc. (MRNA). They have made 15 open-market trades across 3 companies since 2019, most recently 2026-09-08.
CIK 0001643746
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.9M since 2022, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-08 | 2026-09-10 | $209.82 | $3.6M | -5.9% | -5.4% | — |
| RVMD | SELL · 10b5-1 | 2026-08-31 | 2026-09-02 | $203.24 | $11.4M | -2.1% | -1.3% | — |
| RVMD | BUY | 2022-07-22 | 2022-07-25 | $20.00 | $1.0M | -6.1% | +0.1% | -20.0% |
| COWN | BUY | 2022-02-25 | 2022-02-28 | $30.03 | $901K | -11.8% | -9.8% | -11.7% |
| MRNA | SELL | 2020-06-02 | 2020-06-04 | $58.30 | $14.1M | +10.0% | +1.1% | +10.7% |
| MRNA | SELL | 2020-05-27 | 2020-05-28 | $51.13 | $12.3M | +1.4% | +8.1% | +22.7% |
| MRNA | SELL | 2020-05-15 | 2020-06-04 | $63.80 | $166K | +10.0% | +1.1% | +10.7% |
| MRNA | SELL | 2020-05-15 | 2020-05-19 | $81.08 | $40.4M | -11.2% | -7.2% | -0.4% |
| MRNA | SELL | 2020-05-12 | 2020-05-14 | $64.49 | $31.1M | -18.2% | +4.4% | +9.0% |
| MRNA | SELL | 2020-04-15 | 2020-04-16 | $36.19 | $1.4M | -2.2% | +63.5% | +63.9% |
| MRNA | SELL | 2020-03-16 | 2020-03-18 | $26.16 | $1.0M | -7.0% | +42.9% | +96.3% |
| MRNA | SELL | 2020-03-04 | 2020-03-06 | $27.71 | $554K | +5.3% | +15.5% | +102.0% |
| MRNA | SELL | 2020-02-25 | 2020-02-27 | $28.47 | $1.1M | -4.4% | +30.4% | +123.2% |
| MRNA | SELL | 2020-02-07 | 2020-02-11 | $23.06 | $1.5M | -5.3% | +13.5% | +240.6% |
| MRNA | SELL | 2020-01-27 | 2020-01-29 | $23.02 | $1.1M | +12.4% | +23.2% | +127.5% |
| MRNA | SELL · 10b5-1 | 2020-01-22 | 2020-01-23 | $23.04 | $46K | -3.4% | -13.9% | +137.0% |
| MRNA | SELL | 2019-12-06 | 2019-12-09 | $19.99 | $4.7M | +3.4% | -4.3% | +29.3% |
| MRNA | SELL | 2019-12-06 | 2019-12-09 | $20.00 | $4.8M | +3.4% | -4.3% | +29.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.